Truist lifts Boston Scientific stock target to $120, maintains Buy
Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...
Truist initiates Hannon Armstrong stock with Buy, $40 target
Truist Securities began coverage on Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NYSE:HASI) with a positive outlook, assigning a Buy rating and setting a price target of $40.00 for the ...
Truist Financial Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Eli Lilly & Co (LLY – Research Report).
Truist Financial Reaffirms Their Buy Rating on Universal Technical Institute (UTI)
Truist Financial analyst Jasper Bibb maintained a Buy rating on Universal Technical Institute (UTI – Research Report) today and set a price ...